| 1 |
Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025[J]. CA Cancer J Clin, 2025, 75(1): 10-45.
|
| 2 |
Cañellas-socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer[J]. Nat Rev Gastroenterol Hepatol, 2024, 21(9): 609-625.
|
| 3 |
Rahbari NN, Carr PR, Jansen L, et al. Time of metastasis and outcome in colorectal cancer[J]. Ann Surg, 2019, 269(3): 494-502.
|
| 4 |
Liu JL, Xu X, Rixiati Y, et al. Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells[J]. Cell Metab, 2024, 36(6): 1320-34.e9.
|
| 5 |
Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics[J]. Trends Pharmacol Sci, 2023, 44(4): 222-236.
|
| 6 |
Castaneda M, Den Hollander P, Kuburich NA, et al. Mechanisms of cancer metastasis[J]. Semin Cancer Biol, 2022, 87: 17-31.
|
| 7 |
Gupta GP, Massagué J. Cancer metastasis: building a framework[J]. Cell, 2006, 127(4): 679-695.
|
| 8 |
Yuan Z, Li Y, Zhang S, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments[J]. Mol Cancer, 2023, 22(1): 48.
|
| 9 |
Smart JA, Oleksak JE, Hartsough EJ. Cell adhesion molecules in plasticity and metastasis[J]. Mol Cancer Res, 2021, 19(1): 25-37.
|
| 10 |
Terry S, Engelsen AST, Buart S, et al. Hypoxia-driven intratumor heterogeneity and immune evasion[J]. Cancer Lett, 2020, 492: 1-10.
|
| 11 |
Tang J, Chen Z, Zhang D, et al. ENO2 drives tumor cell-induced M2 macrophage polarization to promote colorectal cancer liver metastasis[J]. Signal Transduct Target Ther, 2026, 11(1): 166.
|
| 12 |
俞颖倩,徐兴祥. 淋巴结转移与非转移对原发性支气管肺癌免疫微环境及免疫治疗的影响[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(6): 1027-1030.
|
| 13 |
Wolde T, Bhardwaj V, Pandey V. Current bioinformatics tools in precision oncology[J]. Med Comm (2020), 2025, 6(7): e70243.
|
| 14 |
Jia Q, Chu H, Jin Z, et al. High-throughput single-cell sequencing in cancer research[J]. Signal Transduct Target Ther, 2022, 7(1): 145.
|
| 15 |
汪艳,孙美玲,闵凌峰. 基于TCGA数据库肺腺癌铁死亡相关基因CA9的鉴定[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(6): 888-894.
|
| 16 |
Prakash J, Shaked Y. The interplay between extracellular matrix remodeling and cancer therapeutics [J]. Cancer Discov, 2024, 14(8): 1375-1388.
|
| 17 |
Winkler J, Abisoye-ogunniyan A, Metcalf KJ, et al. Concepts of extracellular matrix remodelling in tumour progression and metastasis[J]. Nat Commun, 2020, 11(1): 5120.
|
| 18 |
Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics[J]. Trends Mol Med, 2002, 8(4 Suppl): S62-S67.
|
| 19 |
Seo J, Yun JE, Kim SJ, et al. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment [J]. Pflugers Arch, 2022, 474(6): 591-601.
|
| 20 |
Zaidi N, Swinnen JV, Smans K. ATP-citrate lyase: a key player in cancer metabolism [J]. Cancer Res, 2012, 72(15): 3709-3714.
|
| 21 |
Lee JV, Carrer A, Shah S, et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation[J]. Cell Metab, 2014, 20(2): 306-319.
|
| 22 |
Gautam J, Wu J, Lally JSV, et al. ACLY inhibition promotes tumour immunity and suppresses liver cancer[J]. Nature, 2025, 645(8080): 507-517.
|
| 23 |
Correction: acetyl-CoA metabolism supports multistep pancreatic tumorigenesis[J]. Cancer Discov, 2024, 14(9): 1757.
|
| 24 |
Li W, Lin M, ZHAO Y, et al. Cholesterol synthases suppress metastasis and stemness through PDIA4/ACLY or SYVN1/SCD1 axis in advanced colorectal cancer[J]. Commun Biol, 2026, 9(1): 795.
|
| 25 |
Lin R, Tao R, Gao X, et al. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth[J]. Mol Cell, 2013, 51(4): 506-518.
|
| 26 |
Wellen KE, Hatzivassiliou G, Sachdeva UM, et al. ATP-citrate lyase links cellular metabolism to histone acetylation[J]. Science, 2009, 324(5930): 1076-1080.
|
| 27 |
Xiang W, Lv H, Xing F, et al. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation[J]. Sci Adv, 2023, 9(49): eadi2465.
|
| 28 |
Inoue C, Miki Y, Fukuda T, et al. Cancer-associated fibroblast marker signatures and stromal composition in usual interstitial pneumonia-associated lung adenocarcinoma: an analysis using a proteomic-immunohistochemical approach[J]. Virchows Arch, 2025, doi: 10.1007/s00428-025-04254-8.
|
| 29 |
Tong X, Poramba-liyanage DW, Van Hoolwerff M, et al. Isolation and tracing of matrix-producing notochordal and chondrocyte cells using ACAN-2A-mScarlet reporter human iPSC lines[J]. Sci Adv, 2024, 10(43): eadp3170.
|
| 30 |
Barahona RA, Kwang NE, Kono-soosaipillai AR, et al. Aggrecan protects against plaque accumulation and is essential for proper microglial responses to plaques[J]. Cell Rep, 2025, 44(8): 116064.
|
| 31 |
Wu Y, Yang S, Ma J, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level[J]. Cancer Discov, 2022, 12(1): 134-153.
|